AT1 4.76% 2.2¢ atomo diagnostics limited

Ann: Access Bio receives FDA clearance for COVID-19 antibody test, page-20

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 141 Posts.
    lightbulb Created with Sketch. 31
    Good upturn, however AT1 still have some ground to make up.

    Additional upturn may result from some of the following;

    1. Revised agreement with Access Bio to increase supply
    2. Lumos obtain FDA approval for FebriDx
    3. Rapid Antigen Test gets some traction in Aus/NZ

    Hopefully soon.
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.2¢
Change
0.001(4.76%)
Mkt cap ! $14.06M
Open High Low Value Volume
2.3¢ 2.5¢ 2.2¢ $24.03K 1.041M

Buyers (Bids)

No. Vol. Price($)
6 541875 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.3¢ 699206 3
View Market Depth
Last trade - 15.56pm 13/11/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.